Drug profile · INN
tecovirimat monohydrate
TECOVIRIMAT SIGA
tecovirimat monohydrate (TECOVIRIMAT SIGA) is a envelope phospholipase opg057 inhibitor.
EMA: approved Antiinfectives for systemic use (J05) J05AX24
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — tecovirimat monohydrate
- Class
- Antiinfectives for systemic use (J05)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
tecovirimat monohydrate (TECOVIRIMAT SIGA) is a envelope phospholipase opg057 inhibitor.
Key facts
INN tecovirimat monohydrate
Brand TECOVIRIMAT SIGA
Mechanism Envelope phospholipase OPG057 inhibitor
Target Envelope phospholipase OPG057
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AX24
Mechanism of action
Envelope phospholipase OPG057 inhibitor
Primary target: Envelope phospholipase OPG057
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tecovirimat monohydrate?
tecovirimat monohydrate (TECOVIRIMAT SIGA) is a envelope phospholipase opg057 inhibitor.
What is the brand name for tecovirimat monohydrate?
TECOVIRIMAT SIGA is a marketed brand name for tecovirimat monohydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.